Connection
Ronald Sokol to F2-Isoprostanes
This is a "connection" page, showing publications Ronald Sokol has written about F2-Isoprostanes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.335 |
|
|
|
-
Sundaram SS, Halbower AC, Klawitter J, Pan Z, Robbins K, Capocelli KE, Sokol RJ. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children. J Pediatr. 2018 07; 198:67-75.e1.
Score: 0.149
-
Sundaram SS, Halbower A, Pan Z, Robbins K, Capocelli KE, Klawitter J, Shearn CT, Sokol RJ. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol. 2016 09; 65(3):560-9.
Score: 0.132
-
Kauffman LD, Sokol RJ, Jones RH, Awad JA, Rewers MJ, Norris JM. Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. Free Radic Biol Med. 2003 Sep 15; 35(6):551-7.
Score: 0.054